LHC Acquires OMNIABIOS to Strengthen its Position in Nutritional and Health Ingredients
date:Mar 10, 2014
hich is a natural fit with LHC.

SAM-e also fits perfectly well with LHCs existing worldwide sale channels and customer bases as it can be sold in the Business-to-Business market to both dietary supplement producers that make products containing SAM-e and pharmaceutical companies that produce medication containing SAM-e. Omniabios has the GMP certificate for producing SAM-e as an API (Active Pharmaceutical Ingredient).

This will allow LHC to strengthen its position in the production of pharmace
2/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/21 06:11